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Abstract
AIM: To develop an animal model that encompasses 
the different facets of non-alcoholic steatohepatitis 
(NASH), which has been a challenge.
METHODS: In this study, we used a high fat diet (HFD) 
feeding supplemented with fructose and sucrose in 
the water mimicking the high-fructose corn syrup that 
is abundant in the diet in the United States. We used 
C57Bl/6 wild-type mice for short and long-term feed-
ings of 6 and 16 wk respectively, and evaluated the ex-
tent of liver damage, steatosis, and inflammasome acti-
vation. Our methods included histopathological analysis 
to assess liver damage and steatosis, which involved 
H and E and oil-red-o staining; biochemical studies to 
look at ALT and triglyceride levels; RNA analysis using 
quantitative polymerase chain reaction; and cytokine 
analysis, which included the enzyme-linked immuno-
sorbent assay method to look at interleukin (IL)-1β and 
tumor necrosis factor-α (TNFα) levels. Furthermore, 
at each length of feeding we also looked at insulin re-
sistance and glucose tolerance using insulin tolerance 
tests (ITT) and glucose tolerance tests.
RESULTS: There was no insulin resistance, steatosis, 
or inflammasome activation at 6 wk. In contrast, at 
16 wk we found significant insulin resistance demon-
strated by impaired glucose and ITT in male, but not 
female mice. In males, elevated alanine aminotrans-
ferase and triglyceride levels, indicated liver damage 
and steatosis, respectively. Increased liver TNFα and 
monocyte chemoattractant protein-1 mRNA and pro-
tein, correlated with steatohepatitis. The inflammasome 
components, adaptor molecule, Aim2, and NOD-like 
receptor 4, increased at the mRNA level, and functional 
inflammasome activation was indicated by increased 
caspase-1 activity and IL-1β protein levels in male mice 
fed a long-term HFD. Male mice on HFD had increased 
α-smooth muscle actin and pro-collagen-1 mRNA indi-
cating evolving fibrosis. In contrast, female mice dis-
played only elevated triglyceride levels, steatosis, and 
no fibrosis.
CONCLUSION: Our data indicate gender differences in 
NASH. Male mice fed a long-term HFD display steato-
hepatitis and inflammasome activation, whereas female 
mice have steatosis without inflammation. 
© 2014 Baishideng Publishing Group Inc. All rights reserved.
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Core tip: Our work shows that there are gender differ-
ences in the development of non-alcoholic steatohepa-
titis. We used a high fat diet feeding supplemented 
with fructose and sucrose in mice, to mimic the high-
fructose corn syrup that is abundant in the western 
diet. There is preferential steatohepatitis and inflam-
masome activation in male mice, whereas female mice 
display steatosis without inflammation.
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INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) affects ap-
proximately one third of  the Western population and 
75% of  obese individuals[1,2]. It has become the most 
common cause of  elevated liver enzymes in the Western 
world and will continue to be on the rise with the obe-
sity epidemic[3-6]. The spectrum of  NAFLD ranges from 
simple steatosis, which consists of  intracellular lipid ac-
cumulation resulting in a fatty liver, to non-alcoholic ste-
atohepatitis (NASH), which is characterized by the pres-
ence of  inflammatory cells and necroinflammation, and 
fibrosis that develops in 20% of  patients with NASH. 
These patients can progress to cirrhosis and hepatocel-
lular carcinoma[1,7-9]. Factors determining the progression 
of  NAFLD and strategies for effective treatment remain 
elusive. NASH is two to three times more common in 
men than women until after the age of  60, after which 
the prevalence is higher in women[10]. In animal models, 
there has been a lack of  consensus as to the role of  gen-
der on the development of  NAFLD[11-13].
The progression of  NAFLD is centered around in-
flammation, and inflammasomes are major contributors 
to this process. Inflammasomes are intracellular multi-
protein complexes that sense endogenous and exogenous 
danger signals through NOD-like receptors (NLRs)[14-16]. 
Components of  intracellular inflammasome complexes 
are the sensors (Aim2, NLRP3 or NLRC4), adaptor mol-
ecule (ASC), and pro-caspase-1[14,17]. Inflammasome ac-
tivation results in cleavage of  pro-caspase-1 to activated 
caspase-1, which promotes cleavage and activation of  
pro-inflammatory cytokines [pro-interleukin-1β (pro-IL-
1β) and pro-IL-18] resulting in a sustained inflammatory 
response[18,19]. It has been shown that the methionine-
choline deficient (MCD) diet, induces significant up-
regulation of  the NACHT, LRR, and PYD domains-
containing protein 3 (NALP3) inflammasome, and that a 
9-mo HFD feeding can also cause NALP3 activation[20].
In this study, we performed a HFD feeding for a 
short-term (6-wk) and long-term (16-wk) duration that 
included both male and female mice. Our data demon-
strates that steatohepatitis and inflammasome upregula-
tion and activation are observed in male mice, but not 
female mice, after a 16-wk HFD feeding.
MATERIALS AND METHODS
Animal studies 
This study was approved by the Institutional Animal 
Care and Use Committee of  the University of  Massa-
chusetts Medical School. Principles of  laboratory animal 
care were followed. Male and Female C57Bl/6 wild-type 
mice that were 8-10 wk old (n = 10 per group) (Jackson 
Laboratory) were fed either a control chow diet or a 
high-fat, high-carbohydrate diet [Surwit diet (58% kcal % 
fat); Research Diets, New Brunswick, NJ, United States] 
with drinking water supplemented with a high-fructose 
corn syrup equivalent consisting of  a total of  42 g/L of  
carbohydrates at a ratio of  55% fructose (Acros Organ-
ics, Morris Plains, NJ, United States) and 45% sucrose 
(Sigma-Aldrich, St. Louis, MO, United States) by weight, 
based on the study by Kohli et al[21]. The mice were given 
ad libitum access to the food for 6 or 16 wk. 
Biochemical analysis and cytokine measurements
Serum alanine aminotransferase levels were measured 
using a kinetic method (D-TEK, Bensalem, PA, United 
States), and liver triglyceride levels were determined us-
ing an L-type triglyceride H kit (Wako Chemicals United 
States, Inc., Richmond, VA, United States). Mouse IL-
1β enzyme-linked immunosorbent assay (ELISA) kit was 
purchased from R and D Systems (Minneapolis, MN). 
Mouse TNF-α kit was purchased from BD Bioscience 
(San Jose, CA, United States), monocyte chemoattractant 
protein 1 (MCP-1) ELISA kit was purchased from Biole-
gend (San Diego, CA, United States).
Histopathological analysis
Sections of  formalin-fixed livers were stained with 
hematoxylin-eosin. Frozen samples were also stained 
with Oil-Red-O that were made at the optimal cutting 
temperature. Slides were analyzed using microscopy using 
Image J and Microsuite (Olympus Soft Imaging Solutions 
GmbH, Munster, Germany).
Glucose tolerance tests 
Glucose levels were measured after 14 wk feeding fol-
lowing an overnight fast. Mice were injected IP with 40% 
glucose (Sigma, St. Louis, MO, United States) at 2 mg/kg 
body weight and glucose levels were obtained at 0, 30, 75, 
120 and 180 min. Blood samples were obtained by tail 
nick and glucose levels were measured using a GlucCell 
glucose monitor and strips. A subset of  mice had blood 
collected by facial vein puncture at time point 0 and 
30 min for serum insulin measurement using a mouse 
enzyme-linked immunosorbent assay kit (ALPCO, Salem, 
NH, United States). 
Insulin tolerance tests 
After 15 wk of  feeding and after an overnight fast, mice 
were injected IP with 0.75 U/kg body weight of  recom-
binant human insulin (Novolin, Novo Nordisk, Bags-
vaerd, Denmark). Glucose levels were measured in the 
same way as in the glucose tolerance tests (GTT) at time 
points 0, 30, 75 and 120 min following insulin injection. 
RNA analysis 
RNA was purified using a RNeasy kit (Qiagen Sciences, 
Germantown, MD, United States) with the on-column 
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DNA digestion (Qiagen Sciences, Germantown, MD, 
United States). Complementary DNA was transcribed 
using a reverse-transcription system (Promega Corp., 
Madison, WI, United States). Real-time quantitative poly-
merase chain reaction (qPCR) was performed with an 
iCycler (Bio-Rad Laboratories, Inc., Hercules, CA, United 
States) using SYBR Green as the detector of  double-
started DNA, as previously described[22]. 
Caspase activity assay
Caspase-1 activity was determined using freshly prepared 
whole liver lysates with a colorimetric assay. The analysis 
was based on the cleavage of  the WEHD-pNA (Trp-
Glu-His-Asp-p-nitroanilide) substrate (R and D Systems, 
Minneapolis, MN, United States). 
Statistical analysis 
Statistical significance was determined using the nonpara-
metric Kruskal-Wallis test and the Mann-Whitney test 
when appropriate. Data are presented as means and stan-
dard errors and are considered statistically significant for 
P ≤ 0.05.
RESULTS
Long-term HFD results in increased body weight and 
insulin resistance
Male mice fed a short-term 6-wk HFD gained signifi-
cantly more weight than chow-fed controls. Female mice 
did not gain significant weight on the HFD compared 
to chow fed mice at 6 wk (Figure 1A). In contrast, at 16 
wk, both male and female mice gained significantly more 
weight on a HFD than chow fed mice (Figure 1B).
GTT were performed on a subset of  mice one week 
before being euthanized. There was no difference in glu-
cose levels following glucose injection at any time point 
in male or female mice after a short-term HFD (data not 
shown). In mice fed a long-term HFD, males showed 
significantly higher glucose levels 180 min after glucose 
injection than those on a chow diet (Figure 2A). Female 
mice on a long-term HFD diet showed no significant 
difference in glucose levels at any time point following 
glucose injection compared to controls (Figure 2B).
Insulin tolerance test was also performed one week 
prior to euthanasia. In the short-term feedings, male 
mice had significantly increased glucose levels compared 
to chow fed mice at the 120-min time point (Figure 2C), 
whereas female mice had no difference in glucose levels 
between the groups at any time point (Figure 2D). In the 
group that received a long-term HFD, males had signifi-
cantly higher glucose levels at all time points following 
insulin injection compared to chow fed males (Figure 
2E), whereas females had no difference in glucose levels 
compared to chow fed controls (Figure 2F). 
Serum insulin levels before and 30 min after glucose 
injection showed no significant difference in either gen-
der after a 6-wk HFD feeding compared to chow fed 
controls (Figure 3A and B). In contrast, insulin levels 
were elevated in long-term HFD male mice 30 min after 
glucose injection compared to chow fed controls (Figure 
3C). No change in insulin levels were detected in female 
mice fed the long-term HFD (Figure 3D). 
Long-term HFD feeding results in steatohepatitis in male 
mice, but only steatosis in female mice
To assess liver steatosis and inflammation, liver sections 
were evaluated histologically using hematoxylin and eosin 
and Oil-Red-O staining. Neither gender showed changes 
in histology after a short-term (6-wk) HFD feeding com-
pared to chow diet (data not shown). However, both male 
and female mice undergoing a long-term HFD feeding 
had significantly more micro and macrovesicular steatosis 
than chow fed controls (Figure 4A and B). Steatosis was 
further evaluated by triglyceride levels in the liver. Both 
male and female mice had significantly elevated liver 
triglyceride levels compared to chow fed mice at 16 wk 
(Figure 4C). However, male mice on a long-term HFD 
had higher triglyceride levels than female mice on the 
same diet (Figure 4C). 
Liver damage was assessed by alanine aminotrans-
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Figure 1  Effect of high fat diet feeding on body weight. Male and female C57Bl/6 mice were fed with either a high fat diet (HFD) supplemented with sucrose and 
fructose in the drinking water, or with a control chow diet for 6 or 16 wk. Body weights were recorded during both the short-term (6 wk, A), and long-term (16 wk, B) 
feedings. bP < 0.01 vs chow fed controls, n = 10/group. 
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In the livers of  long-term HFD males, TNFα mRNA 
levels were increased approximately 4-fold, whereas no 
significant change was noted in the females (Figure 5B). 
A similar trend was seen in TNFα protein levels in the 
liver, with a 2-fold increase in the long-term HFD males, 
and no increase in the long-term HFD females (Figure 
5C). MCP-1 is a chemokine that contributes to steatosis 
and inflammatory cell infiltration. In a pattern similar to 
TNFα, no change in levels of  MCP-1 protein was seen 
in mice fed a short-term HFD compared to chow-fed 
ferase (ALT) levels. No change in ALT levels in either 
gender was noted after a short-term HFD feeding (data 
not shown). Following a 16-wk HFD, male mice showed 
significantly higher levels of  ALT than chow fed controls, 
whereas no significant change in ALT was noted in the 
long-term female HFD group (Figure 4D). 
Next, we evaluated the presence of  inflammation in 
the liver. There was no change in protein levels of  tumor 
necrosis factor-α (TNFα) in the livers of  either male or 
female mice in the short-term HFD group (Figure 5A). 
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Figure 2  High fat diet results in insulin resistance in male mice after 16 wk high fat diet feeding. Male and female mice were fed with either high fat diet (HFD) 
or chow diet for 6 or 16 wk. Glucose tolerance test (GTT) was performed: glucose levels were measured 0, 30, 75, 120 and 180 min after ip glucose injection in male (A) 
and female mice (B) fed with HFD for 16 wk. Insulin tolerance test (ITT) was performed: glucose levels were measured 0, 30, 75 and 120 min after ip insulin injection 
in male and female mice fed with HFD for 6 wk (C and D, respectively) or 16 wk (E and F, respectively). aP < 0.05, bP < 0.01 vs chow fed controls, n = 5/group, P = 0.03 
vs chow fed controls in GTT-males, 16 wk, n = 5/group. 
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controls (Figure 5D). MCP-1 mRNA levels in the liver 
were increased in the long-term HFD males compared to 
chow fed mice, whereas no change was noted in the long-
term HFD females (Figure 5E). Long-term HFD male 
mice showed a 2-fold increase in MCP-1 protein in the 
liver compared to chow-fed mice, whereas no change in 
MCP-1 protein was seen in female mice (Figure 5F).
Inflammasome components are upregulated and 
activated in male mice following a long-term HFD, but 
not females
We evaluated inflammasome activation only in the long-
term 16-wk HFD feeding based on previous studies that 
a longer feeding is needed for inflammasome activa-
tion[20]. We found an increase in mRNA in components 
of  the inflammasome only in male mice fed a long-term 
HFD, including ASC, Aim2, and NLRC4 (Figure 6A and 
B). Inflammasome activation was indicated by increased 
caspase-1 activity (Figure 6C) and increased total IL-1β 
protein levels (Figure 6D) in the liver of  male mice fed a 
long-term HFD.
Fibrosis markers are elevated in males who received 
long-term HFD 
Because liver inflammation can trigger fibrosis, fibrotic 
markers were evaluated in mice fed a long-term HFD. El-
evation in mRNA levels of  both α-smooth muscle actin 
(αSMA) (Figure 7A) and pro-collagen-1 (Figure 7B) are 
seen in male mice who received long-term HFD feeding, 
whereas no significant change was seen in females com-
pared to chow fed controls. Because of  the early stage 
of  fibrosis, we found no increase in αSMA protein levels 
(data not shown). 
DISCUSSION
NASH has become a global epidemic and continued 
research into the pathogenesis resulting in inflammation 
and steatosis requires a robust animal model, which has 
remained a challenge[23]. Here we show that mice fed a 
HFD supplemented with fructose and sucrose in the 
drinking water for 16 wk, results in steatohepatitis and 
moderate activation of  the inflammasome pathway in 
male, but not female, mice.
Our study evaluated gender differences on the degree 
of  inflammation, steatosis, and fibrosis between male and 
female mice fed a high fat diet enriched in fructose and 
sucrose for 6 or 16 wk. We found evidence of  steatohep-
atitis in male mice fed a long-term HFD as demonstrated 
by an increase in ALT, triglycerides, TNFα, and MCP-1, 
whereas in females only an increase in triglycerides was 
seen, consistent with the presence of  steatosis, but no 
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Figure 3  Elevated insulin levels in male mice after long-term high fat diet feeding. Insulin levels were measured using enzyme-linked immunosorbent assay 
prior to and 30 min after glucose stimulation in males (A) and females (B), following a short-term high fat diet (HFD) feeding, and males (C) and females (D), after a 
long-term HFD feeding. aP < 0.05 vs chow fed controls, n = 5/group.
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steatohepatitis. Several studies have investigated gender 
on the role of  NAFLD progression with no consistent 
outcome. Kamada et al[13] show that estrogen plays a 
role in protection of  liver injury following high fat diet, 
whereas another group showed that there was no protec-
tion in MCD diet induced steatohepatitis in female mice 
that received an ovariectomy or antiestrogen treatment[11]. 
Yet another study showed that female mice fed a chow 
diet supplemented with 30% fructose in the drinking wa-
ter, displayed more pronounced inflammation than male 
mice[12]. In terms of  other liver diseases in humans, men 
are about three to five times more likely than women 
to develop hepatocellular carcinoma (HCC)[24]. The un-
derlying mechanism leading to a decreased incidence in 
women is thought to be due to estrogen suppression of  
IL-6 in Kupffer cells[25] and due to increased androgen 
receptor signaling by testosterone in men, resulting in in-
creased hepatocyte proliferation[26]. Furthermore, studies 
have shown that the male gender is an independent risk 
factor in the progression of  cirrhosis[27,28], and that young 
women have the lowest rate of  developing cirrhosis from 
chronic hepatitis C[29]. Further studies need to be done 
looking into the differences of  liver injury in males and 
females. Our study in mice indicates gender differences 
that were dependent on the length of  HFD feeding and/
or the estrogen status of  female mice. 
Previous work has shown that various high fat diet 
feedings induce the inflammasome and that knock-outs 
of  parts of  the inflammasome pathway can result in 
protection from HFD induced obesity[20,30]. Both up-
regulation of  inflammasome expression and activation 
occurred in male mice after 16 wk. We show that there 
Chow
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Figure 4  Long-term high fat diet feeding results in steatohepatitis in male mice, and steatosis in female mice. Male and female mice were fed with either high 
fat diet (HFD) or control chow diet for 6 or 16 wk. A, B: Liver tissue was subjected to HE of male (A) and Oil-Red-O staining (B) (× 100). Dark arrow: Macrovesicular 
steatosis, white arrow: Microvesicular steatosis. One representative slide from n = 5/group is shown; C, D: Liver triglyceride levels (C) were evaluated in mice fed with 
HFD for 16 wk. Serum alanine aminotransferase (ALT) levels were measured after long-term HFD feeding (D). 
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is an increase in mRNA in parts of  the inflammasome 
pathway, including ASC, Aim2, and NLRC4, as well as 
an increase in caspase-1 activity and IL-1β protein in the 
liver, after a 16-wk HFD feeding in male mice, whereas 
mice fed a HFD for 9 mo, show an increase in mRNA 
in all parts of  the NALP3 inflammasome (NALP3, 
ASC, Caspase-1, Pannexin, and IL-1β)[20]. This finding 
suggests that longer access to a HFD is required to ob-
tain complete inflammasome activation and thus more 
inflammation and liver damage. Another possibility is 
that changing the composition of  the diet could result 
in more extensive liver damage and fibrosis, such as the 
combination of  dietary fat and dietary cholesterol[31]. It is 
conceivable that changes in fatty acid composition due to 
the diet affects inflammation, for example saturated fatty 
acids result in inflammasome activation[20].
The limitation of  existing animal models of  NASH 
that are based on genetic modifications and no single 
model captures the different aspects of  human fatty liver 
disease[23,32,33]. MCD extensively used in our previous 
studies results in severe steatohepatitis in a short period 
of  time[20,34], however in contrast to human fatty liver 
disease, mice lose weight and lack insulin resistance[23]. To 
use a model that results in steatohepatitis, in addition to 
weight gain and insulin resistance, we chose HFD model 
consisting mainly of  medium chain hydrogenated satu-
rated trans fatty acids supplemented with fructose and 
sucrose in the drinking water, similar to the high-fructose 
corn syrup that is so widespread in the United States[21]. 
Of  note, there has been a wide variety in the extent of  
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Figure 5  Long-term high fat diet results in hepatic inflammation in male mice. A-C: Liver tumor necrosis factor-α (TNFα) protein levels (A) were evaluated in the 
short-term feeding levels of TNFα in the liver were analyzed at the mRNA (B) and protein (C) level after a long-term feeding; D-F: Monocyte chemoattractant protein 
1 (MCP-1) protein levels (D) were evaluated in the short-term feeding. Levels of MCP-1 in the liver were analyzed at the mRNA (E) and protein (F) level after a long-
term feeding. bP < 0.01 vs chow fed controls, n = 10/group.
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inflammation and steatosis seen in high fat diet feedings. 
Some groups have shown fibrosis after only 6 wk of  
feeding[35], whereas others have needed 24 wk or longer 
to see fibrosis[36,37]. This variation could be due to vari-
ances in the composition of  the diet and in differences in 
gut microbiota in the mice in each individual study. 
In summary, our data shows that gender differences 
exist in the development of  steatohepatitis and inflam-
masome activation following a long-term high fat diet 
feeding. Male mice display steatohepatitis in addition to 
inflammasome upregulation and activation, whereas fe-
male mice develop steatosis and do not show activation 
of  the inflammasome pathway. 
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tance with the glucose and insulin tolerance tests.
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Background
Non-alcoholic fatty liver disease is one of the most common causes of liver 
disease in the Western world and continues to be on the rise. Developing an 
animal model that closely resembles human non-alcoholic fatty liver disease 
has remained a challenge. Furthermore, it is known that males are more likely 
than females to develop cirrhosis.
Research frontiers
Developing an animal model that resembles non-alcoholic fatty liver disease in 
humans is an important area. Further knowledge into non-alcoholic fatty liver 
disease can help further knowledge in the field. 
Innovations and breakthroughs
Previous studies have shown that feeding mice a high fat diet with added su-
crose and fructose results in steatohepatitis and fibrosis. A number of studies 
have looked at gender differences in non-alcoholic fatty liver disease with no 
consistent outcome. In the present study, the authors looked at the effect of 
both a short-term and long-term high fat diet feeding supplemented with su-
crose and fructose in both male and female wild-type mice. This paper showed 
that male mice fed a long-term high fat diet display steatohepatitis and inflam-
masome activation, whereas female mice have steatosis without inflammation. 
Applications
Further studies looking into why there are gender differences in developing non-
alcoholic fatty liver disease are warranted. These studies could lead to potential 
treatments for non-alcoholic fatty liver disease.
Peer review
The manuscript presents some animal data on the gender differences regarding 
the consequences of high fat feeding. The manuscript is in a very good condi-
tion. Although the animal model for gender difference may be questioned and 
translation of the data to the clinical area is difficult, the data may be attractive 
for some of the readers.
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